Carotid body tumors, although representing about 65% of head and neck paragangliomas, are rare neoplasms. Doppler ultrasonography, contrast-enhanced computed tomography (CECT), and MRI have been routinely used in the diagnosis of carotid body tumor. We hereby represent a case of 56-year-old male suspected to have lymph node metastasis from carcinoma pyriform sinus detected as carotid body tumor in fluorodeoxyglucose positron-emission tomography-CECT imaging and subsequently confirmed by histopathology.
A 56-year-old male patient presented with swelling in the left side of the neck for the past 2 months. He had a previous history of squamous cell carcinoma of left pyriform sinus which was treated with chemoradiotherapy 5 years back. In view of the previous history of carcinoma left pyriform sinus, a provisional diagnosis of metastatic cervical lymphadenopathy has been made. Subsequently, the patient has been referred for fluorodeoxyglucose positron-emission tomography-computed tomography (FDG PET/CT) for further assessment. FDG PET/CT study revealed a hypermetabolic soft-tissue density nodule measuring approximately 2.2 cm × 2.5 cm in the bifurcation of the common carotid artery (maximum standardized uptake value 10. Carotid body tumors (CBTs) are rare, benign neoplasms that originate from the neuroectodermal paraganglion. Originating from the afferent ganglion of the glossopharyngeal nerve, carotid body tumors are generally located at the carotid bifurcation. [1] Physiological activity is rare in these neoplasms, and these tumors generally exhibit a slow rate of growth, most often presenting asymptomatically as a space-occupying mass lesion noted clinically or radiographically. [1, 2] They can occur sporadically or as inherited familial tumors. Patients with multiple endocrine neoplasia type 2, von Hippel-Lindau disease, or neurofibromatosis type 1 are prone to head and neck PG. Approximately 30% of apparently sporadic head and neck PGs are associated with germline mutations in the mitochondrial complex II genes. The described mutations in SDHB, SDHC, and SDHD genes cause one out of four paraganglioma syndromes with similar clinical features. [3] 18F-Fluorodeoxyglucose ( 18 F-FDG) uptake in these tumors is strongly dependent on patient genotype. Increased 18 F-FDG uptake in these tumors can be used clinically to help identify patients in whom SDH mutations should be suspected. [4, 5] The differential diagnosis of carotid body tumor includes cervical lymphadenopathies, branchial cleft cysts, salivary gland tumors, schwannomas, and aneurysms of the carotid artery. [3, 6] Since both CBTs and metastatic cervical lymph 
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